Crossmark

VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experience

Crossref DOI link: https://doi.org/10.1007/s00277-022-05027-y

Published Online: 2022-11-16

Published Print: 2023-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghandili, Susanne https://orcid.org/0000-0001-5655-3155
Alihodzic, Dzenefa

Wiessner, Christian

Bokemeyer, Carsten

Weisel, Katja

Leypoldt, Lisa B.
Funding

Funding for this research was provided by:

Universitätsklinikum Hamburg-Eppendorf (UKE)
License Information

Text and Data Mining valid from 2022-11-16

Version of Record valid from 2022-11-16
More Information

Article History

Received: 14 June 2022

Accepted: 3 November 2022

First Online: 16 November 2022

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below